Stabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder
BLUES
1 other identifier
interventional
150
1 country
1
Brief Summary
The study investigates whether add-on treatment with eyewear that blocks the short wavelengths of visible light (\<500nm) reduces manic symptoms and improves sleep in patients receiving outpatient treatment as usual for bipolar disorder. When in a hypomanic or manic phase, participants will be randomized to receive add-on treatment with either blue blocking or low filtration eyewear from 18 PM to 8 AM daily for 7 days. After this initial intervention phase, the eyewear is used daily for 3 months in either antimanic dose (14 hours) or maintenance dose (2 hours before bedtime).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
April 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedMay 8, 2024
May 1, 2024
1.9 years
February 14, 2024
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Manic symptoms
Change in Young Mania Rating Scale Score, range 0-60, higher scores indicating greater manic symptom load
7 days
Secondary Outcomes (5)
Mood instability
15 weeks
Objective sleep quality
7 days
Objective sleep quality
15 weeks
Subjective sleep quality
7 days
Subjective sleep quality
15 weeks
Study Arms (2)
Blue blocking glasses (BB)
EXPERIMENTALEyewear with orange-tinted lenses that block 99% of short wavelength visible light \< 500 nm
Low filtration glasses (LF)
SHAM COMPARATOREyewear with clear lenses that block 15% of short wavelength light \< 500 nm
Interventions
Eyewear is worn daily from 6 PM to 8 AM during manic/hypomanic state Eyewear is worn daily 2 hours before planned bedtime during euthymic, depressive and mixed state
Eyewear is worn daily from 6 PM to 8 AM during manic/hypomanic state Eyewear is worn daily 2 hours before planned bedtime during euthymic, depressive and mixed state
Eligibility Criteria
You may qualify if:
- Diagnosis of bipolar disorder
- YMRS-score \>13
- Age 18-60 years
- Speaks and writes Danish at a level equal to mother tongue
You may not qualify if:
- Not willing or able to adhere to the protocol
- Severe eye disorder or eye trauma
- Treatment with betablockers
- Sleep disturbances not related to BD (e.g, sleep apnea, restless legs syndrome) • • Substance abuse
- Unwilling to use the electronic self-monitoring system, the Monsenso system
- Prior/current use of BB glasses
- Current/planned pregnancy
- Night shift work
- Suicidality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Psychiatric Center Copenhagen
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars Kessing
Mental Health Center Copenhagen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants are instructed not to discuss the appearance of their designated eyewear with their care providers or the investigator or outcome assessor. Participants are not informed of the exact filtration level of their eyewear.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2024
First Posted
February 21, 2024
Study Start
April 5, 2024
Primary Completion
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share